87 related articles for article (PubMed ID: 9785854)
1. [Peroxidative reactions in the vitreous as related to diabetic retinopathy].
Tanaka Y
Nippon Ganka Gakkai Zasshi; 1998 Sep; 102(9):576-82. PubMed ID: 9785854
[TBL] [Abstract][Full Text] [Related]
2. [The oxidative stress in the cataract formation].
Obara Y
Nippon Ganka Gakkai Zasshi; 1995 Dec; 99(12):1303-41. PubMed ID: 8571853
[TBL] [Abstract][Full Text] [Related]
3. Superoxide dismutase in the anterior chamber and the vitreous of diabetic patients.
Kernell A; Lundh BL; Marklund SL; Skoog KO; Björkstén B
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3131-5. PubMed ID: 1399417
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation in proliferative vitreoretinopathies.
Verdejo C; Marco P; Renau-Piqueras J; Pinazo-Duran MD
Eye (Lond); 1999 Apr; 13 ( Pt 2)():183-8. PubMed ID: 10450379
[TBL] [Abstract][Full Text] [Related]
5. Raman spectroscopy of human vitreous in proliferative diabetic retinopathy.
Sebag J; Nie S; Reiser K; Charles MA; Yu NT
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2976-80. PubMed ID: 8206715
[TBL] [Abstract][Full Text] [Related]
6. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.
Yokoi M; Yamagishi SI; Takeuchi M; Ohgami K; Okamoto T; Saito W; Muramatsu M; Imaizumi T; Ohno S
Br J Ophthalmol; 2005 Jun; 89(6):673-5. PubMed ID: 15923499
[TBL] [Abstract][Full Text] [Related]
7. [Features of lipid peroxidation in the vitreous body and retina during intravitreal hemorrhaging in dithiosone-induced diabetes].
Agaeva RB; Dzhafarov AI
Biull Eksp Biol Med; 1991 Oct; 112(10):376-8. PubMed ID: 1804348
[TBL] [Abstract][Full Text] [Related]
8. Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Iwasaki T; Ohno A; Goto H
Retina; 2011 Oct; 31(9):1951-7. PubMed ID: 21610567
[TBL] [Abstract][Full Text] [Related]
9. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
10. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
11. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.
Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F
Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415
[TBL] [Abstract][Full Text] [Related]
12. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
[TBL] [Abstract][Full Text] [Related]
13. Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy.
Marek N; Raczyńska K; Siebert J; Myśliwiec M; Zorena K; Myśliwska J; Reiwer-Gostomska M; Trzonkowski P
Microvasc Res; 2011 Jul; 82(1):1-5. PubMed ID: 21539846
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
16. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
17. Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.
Gustavsson C; Agardh CD; Agardh E
Acta Ophthalmol; 2013 Aug; 91(5):445-52. PubMed ID: 22520269
[TBL] [Abstract][Full Text] [Related]
18. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
[TBL] [Abstract][Full Text] [Related]
19. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy.
Sebag J; Buckingham B; Charles MA; Reiser K
Arch Ophthalmol; 1992 Oct; 110(10):1472-6. PubMed ID: 1417549
[TBL] [Abstract][Full Text] [Related]
20. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Goto H; Iwasaki T
Retina; 2010 Feb; 30(2):339-44. PubMed ID: 20142713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
